Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current Assets
Cash	$ 1,033	$ 50,433
Receivable from equity method investment	800
Notes receivable - current	131,405
Other current assets	12,389	38,818
Total Current Assets	145,627	89,251
Non-current assets
Plant and equipment	5,400	7,027
Notes receivable, net of unamortized discount of $48,243	177,947
Security deposit	5,000	5,000
Equity method investment	703,778	703,938
Total Non-Current Assets	892,125	715,965
Total Assets	1,037,752	805,216
Current Liabilities
Accounts payable	2,595,191	2,023,375
Federal relief loans – current portion	7,670	9,369
Notes payable, net of unamortized discount of $60,870 and $0, respectively	1,390,229	1,062,007
Convertible debt, net of unamortized discount of $184,626 and $687,503, respectively	4,916,822	3,704,280
Derivative liability	1,569,103	1,434,196
Total Current Liabilities	10,479,015	8,233,227
Non-Current Liabilities
Federal relief loans	150,000	150,000
Total Non-Current Liabilities	150,000	150,000
Total Liabilities	10,629,015	8,383,227
Stockholders’ Equity (Deficit)
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023.
Common stock, $0.0001 par value; 750,000,000 shares authorized, 16,185,552 and13,819,889 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.	1,619	1,382
Additional paid-in-capital	51,926,805	50,656,225
Accumulated deficit	(61,519,687)	(58,235,618)
Total Stockholders’ Equity (Deficit)	(9,591,263)	(7,578,011)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 1,037,752	$ 805,216